Blood Markers and the Microbiome: Two Views of the Same Body

Illustrated comparison of blood testing and gut microbiome sequencing, showing blood markers such as glucose and cholesterol alongside gut microbes, sequencing data, and a human figure.

A blood panel reports what is circulating in your body right now. Gut microbiome sequencing reports which microbes are living in your digestive tract and what they are equipped to do. The two answer different questions. Read together, they show more than either shows alone.

Somewhere in the last few years, this became an either-or question. Blood test or gut test. One or the other, as though you were picking a side. That framing comes from the marketplace rather than from the biology. The body does not work that way, and neither does the research

What does a blood panel actually measure?

A blood draw captures a moment. It tells you what is in circulation at the time the needle went in: how much glucose, how much cholesterol, how much of a given protein or hormone or mineral. That is genuinely powerful information, and the reason your clinician orders it is that decades of research have established what normal looks like for a long list of those values and what it means when one drifts.

The limit is built into the strength. A circulating value is a snapshot of a system in motion. It can move with your sleep, your last meal, a cold you are fighting off, the week you have had. Some markers are stable enough that one reading is meaningful. Others are dynamic by nature, and a single number from a single morning tells you less than you might assume.

Researchers working with a Danish population cohort of 1,199 adults illustrated the point from an unexpected direction. They measured 30 inflammatory signalling proteins in blood, along with 19 other biochemical and physiological measures, and then asked what best accounted for the variation between people. Chronological age, the variable most of us assume is doing the work, was associated with about 40 percent of the inflammatory proteins. Gut microbiota composition accounted for more of the variation than age did in 97 percent of them.

That is a statement about a statistical model across a population, not a reading of any one person. But it points at something worth sitting with. The blood values were real. What explained them was partly living somewhere else.

What does gut sequencing measure instead?

Gut microbiome sequencing does not measure a circulating value. It measures a resident population. Shotgun metagenomic sequencing, a method that reads the DNA of the microbes in a stool sample to identify what is living there and in what amounts, produces a census: which organisms are present, in what proportions, and what metabolic jobs that particular community is equipped to perform.

A community changes more slowly than a blood value does. It also carries different information. Your gut microbes are not passive residents. They ferment what you eat, produce compounds that enter circulation, interact with the lining of your intestine and with your immune system. Several of the things a blood panel detects downstream begin as something a microbe did upstream.

This is why the two readings tend to be complementary rather than redundant. One tells you the state of the water. The other tells you something about the watershed.

Where does each one fall short?

Both measurements have real limits, and the honest version of this conversation names them.

A blood panel is standardised, clinically interpreted, and narrow by design. It was built to answer the question a clinician needs answered: is there a problem now, and does it cross a threshold that calls for action. It is not built to describe the systems producing those values, and it will not tell you why a value sits where it does.

Gut sequencing is broad and still young. There is no approved clinical microbiome test in the United States, which means no clinician can currently use one to make a diagnosis. The science is suggestive rather than settled, the gut is genuinely heterogeneous from person to person, and results describe a community rather than a condition. A sequencing result is information, not a verdict.

There is also the sampling problem, which cuts both ways. One blood draw on one morning, or one stool sample on one day, can both mislead. A three-sample design, taken across days rather than at a single moment, exists precisely because a single reading of a moving system is a thin basis for anything.

And a caution worth stating plainly, because it applies to a finding mentioned earlier in this piece: researchers presenting work at a European diabetes meeting in September reported that across 229,025 people they could identify gut bacterial patterns associated with type 2 diabetes, and that in some people those patterns appeared before blood glucose measures had changed. That was a conference presentation rather than a published paper, the cohort was heavily weighted toward women, and the analysis compares groups rather than following individuals forward. It is an interesting signal about where measurement may be heading. It is not yet a claim anyone should make about a person.

How would I read them together?

Not as a ranking. As two instruments pointed at the same body from different angles.

The practical version looks like this. A blood value tells you where something sits today. A gut profile gives you context for why it might sit there, and a baseline you can compare against later. Neither one instructs you. Both of them give you and your clinician more to work with than a single reading on its own.

Dayhoff Health runs an at-home program that reads both: shotgun metagenomic sequencing of the gut, and a panel drawn from a small at-home blood sample, processed in a CLIA-certified laboratory, the same certification standard that applies to clinical diagnostic labs. The report comes back in plain language with the measurements set alongside each other and a summary designed to be shared with the provider who knows your history. What you do with it is a conversation, not an instruction.

Your annual physical is doing its job. It was simply never designed to describe the rest of the system. Both views are worth having.

Frequently Asked Questions

Is one of these tests better than the other?

They measure different things. A blood panel reports circulating values; sequencing reports which microbes are present and what they can do.

Can gut sequencing replace my bloodwork?

No. It is additional information for a conversation with your provider, not a substitute for clinical testing or care.

Why does one sample sometimes not be enough?

Both blood values and gut communities shift over time, so a reading from a single day can misrepresent a system in motion.

Can I see both for myself?

Yes. Dayhoff Health offers an at-home program that sequences the gut microbiome and reads blood markers, with results delivered in plain language.